Entrada Therapeutics, Inc. Restricted Cash
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2023-03-06
- 2022-12-31: Restricted Cash $4.00M.
- 2022-09-30: Restricted Cash $3.95M.
- 2022-06-30: Restricted Cash $3.95M.
- 2022-03-31: Restricted Cash $3.95M.
| Period end | Restricted Cash |
|---|---|
| 2022-12-31 | $4.00M 10-K · filed 2023-03-06 |
| 2022-09-30 | $3.95M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $3.95M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $3.95M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |